Top Markets
#1 Akedo Akedo +48.15%
#2 TENDIES TENDIES +44.80%
#3 Threshold Network Threshold Network +41.90%
#4 Mubarak Mubarak +24.91%
#5 Cash Cat Cash Cat +20.67%
#6 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#7 MultiversX MultiversX +17.21%
#8 Magma Finance Magma Finance +16.65%
#9 OSK OSK +16.18%
#10 Kite Kite +15.76%
Coin of the day
Akedo Akedo
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
TWi Biotechnology, Inc. TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

6610
Classificação em ações #17311
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm,... TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
Preço da ação
$1.21
Valor de mercado
$248.41M
Variação (1 dia)
4.11%
Variação (1 ano)
79.12%
País
TW
Negociar TWi Biotechnology, Inc. (6610)

Categoria

Healthcare
Receita da TWi Biotechnology, Inc. (6610)
Receita em Sep 2026 TTM: 0
De acordo com os últimos relatórios financeiros da TWi Biotechnology, Inc., a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da TWi Biotechnology, Inc. de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH